Published: 31.5.2022 22:07
All of the drugs developed against COVID-19 have been disastrous in one way or another.
Remdesivir, which to this day is the primary COVID drug approved for use in U.S. hospitals, routinely causes severe organ damage and, often, death Despite that, the U.S. Food and Drug Administration has approved remdesivir for in-hospital and outpatient use in children as young as 1 month old.
Another COVID drug, Paxlovid, will in some cases cause the infection to rebound when the medication is withdrawn. Molnupiravir also has serious safety concerns. Not only might it contribute to cancer and birth defects, it may also supercharge the rate at which the virus mutates inside the patient, resulting in newer and more resistant variants.
They’ve basically become extensions of the drug industry, protecting the drug industry’s interests at the cost of public health.